Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 18:46 | 11/15/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 7 | S.d | -4,815 | 69.32 | 0 | -69 | 20 | D | |||||||||||||||
11/14/24 16:37 | 11/12/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 9 | S.dm | -7,320 | 93.87 | 0 | -78 | -100 | 0 | D | |||||||||||||||
9/6/24 17:48 | 9/5/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Heery Christopher | CA | O | CHIEF ME | 15 | S.dm | -19,834 | 58.33 | 0 | -340 | 30 | D | |||||||||||||||
4/18/24 16:01 | 4/16/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Ware Olivia C | CA | D | 2 | S.d | -1,156 | 62.81 | 0 | -18 | -100 | 0 | D | |||||||||||||||
4/3/24 16:44 | 4/1/24 | ACLX | Health | BioPrd | Biological Products, (No Diag | Elghandour Rami | CA | DO | SEE REMA | 3 | S.m | -5,566 | 61.70 | 0 | -90 | 92 | D | |||||||||||||||
3/25/24 17:30 | 12/14/23 | ACLX | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | 2 | S | -60,350 | 59.84 | 0 | -1,009 | 1,983 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |